Cargando…
Letermovir prophylaxis in T-cell–depleted transplants: breakthrough and rebound infections in the postmarketing setting
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579255/ https://www.ncbi.nlm.nih.gov/pubmed/34614515 http://dx.doi.org/10.1182/bloodadvances.2021005637 |
_version_ | 1784596402912886784 |
---|---|
author | Marzolini, Maria A. V. Mehra, Varun Thomson, Kirsty J. Tholouli, Eleni Bloor, Adrian J. C. Parker, Anne Lovell, Richard Orchard, Kim Publicover, Amy Nicholson, Emma Snowden, John A. Byrne, Jennifer Khan, Anjum Gilleece, Maria H. Errico, Gerardo Lozano, Sara Hurst, Erin Duncan, Nick Pirrie, Jennifer Crea, Philip Carpenter, Ben Pagliuca, Antonio Peggs, Karl S. |
author_facet | Marzolini, Maria A. V. Mehra, Varun Thomson, Kirsty J. Tholouli, Eleni Bloor, Adrian J. C. Parker, Anne Lovell, Richard Orchard, Kim Publicover, Amy Nicholson, Emma Snowden, John A. Byrne, Jennifer Khan, Anjum Gilleece, Maria H. Errico, Gerardo Lozano, Sara Hurst, Erin Duncan, Nick Pirrie, Jennifer Crea, Philip Carpenter, Ben Pagliuca, Antonio Peggs, Karl S. |
author_sort | Marzolini, Maria A. V. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8579255 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Society of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-85792552021-11-10 Letermovir prophylaxis in T-cell–depleted transplants: breakthrough and rebound infections in the postmarketing setting Marzolini, Maria A. V. Mehra, Varun Thomson, Kirsty J. Tholouli, Eleni Bloor, Adrian J. C. Parker, Anne Lovell, Richard Orchard, Kim Publicover, Amy Nicholson, Emma Snowden, John A. Byrne, Jennifer Khan, Anjum Gilleece, Maria H. Errico, Gerardo Lozano, Sara Hurst, Erin Duncan, Nick Pirrie, Jennifer Crea, Philip Carpenter, Ben Pagliuca, Antonio Peggs, Karl S. Blood Adv Research Letter American Society of Hematology 2021-11-09 /pmc/articles/PMC8579255/ /pubmed/34614515 http://dx.doi.org/10.1182/bloodadvances.2021005637 Text en © 2021 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. |
spellingShingle | Research Letter Marzolini, Maria A. V. Mehra, Varun Thomson, Kirsty J. Tholouli, Eleni Bloor, Adrian J. C. Parker, Anne Lovell, Richard Orchard, Kim Publicover, Amy Nicholson, Emma Snowden, John A. Byrne, Jennifer Khan, Anjum Gilleece, Maria H. Errico, Gerardo Lozano, Sara Hurst, Erin Duncan, Nick Pirrie, Jennifer Crea, Philip Carpenter, Ben Pagliuca, Antonio Peggs, Karl S. Letermovir prophylaxis in T-cell–depleted transplants: breakthrough and rebound infections in the postmarketing setting |
title | Letermovir prophylaxis in T-cell–depleted transplants: breakthrough and rebound infections in the postmarketing setting |
title_full | Letermovir prophylaxis in T-cell–depleted transplants: breakthrough and rebound infections in the postmarketing setting |
title_fullStr | Letermovir prophylaxis in T-cell–depleted transplants: breakthrough and rebound infections in the postmarketing setting |
title_full_unstemmed | Letermovir prophylaxis in T-cell–depleted transplants: breakthrough and rebound infections in the postmarketing setting |
title_short | Letermovir prophylaxis in T-cell–depleted transplants: breakthrough and rebound infections in the postmarketing setting |
title_sort | letermovir prophylaxis in t-cell–depleted transplants: breakthrough and rebound infections in the postmarketing setting |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579255/ https://www.ncbi.nlm.nih.gov/pubmed/34614515 http://dx.doi.org/10.1182/bloodadvances.2021005637 |
work_keys_str_mv | AT marzolinimariaav letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting AT mehravarun letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting AT thomsonkirstyj letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting AT tholoulieleni letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting AT blooradrianjc letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting AT parkeranne letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting AT lovellrichard letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting AT orchardkim letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting AT publicoveramy letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting AT nicholsonemma letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting AT snowdenjohna letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting AT byrnejennifer letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting AT khananjum letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting AT gilleecemariah letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting AT erricogerardo letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting AT lozanosara letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting AT hursterin letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting AT duncannick letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting AT pirriejennifer letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting AT creaphilip letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting AT carpenterben letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting AT pagliucaantonio letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting AT peggskarls letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting |